Document Detail


Neurologic complications of arteriovenous malformation embolization using liquid embolic agents.
MedLine Citation:
PMID:  17974613     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: Embolization of arteriovenous malformations (AVMs) is commonly used to achieve nidal volume reduction before microsurgical resection or stereotactic radiosurgery. The purpose of this study was to examine the overall neurologic complication rate in patients undergoing AVM embolization and analyze the factors that may determine increased risk. MATERIALS AND METHODS: We performed a retrospective review of all patients with brain AVMs embolized at 1 center from 1995 through 2005. Demographics, including age, sex, presenting symptoms, and clinical condition, were recorded. Angiographic factors including maximal nidal size, presence of deep venous drainage, and involvement of eloquent cortex were also recorded. For each embolization session, the agent used, number of pedicles embolized, the percentage of nidal obliteration, and any complications were recorded. Complications were classified as the following: none, non-neurologic (mild), transient neurologic deficit, and permanent nondisabling and permanent disabling deficits. The permanent complications were also classified as ischemic or hemorrhagic. Modified Rankin Scale (mRS) scores were collected pre- and postembolization on all patients. Univariate regression analysis of factors associated with the development of any neurologic complication was performed. RESULTS: Four hundred eighty-nine embolization procedures were performed in 192 patients. There were 6 Spetzler-Martin grade I (3.1%), 26 grade II (13.5%), 71 grade III (37.0%), 57 grade IV (29.7%), and 32 grade V (16.7%) AVMs. Permanent nondisabling complications occurred in 5 patients (2.6%) and permanent disabling complications or deaths occurred in 3 (1.6%). In addition, there were non-neurologic complications in 4 patients (2.1%) and transient neurologic deficits in 22 (11.5%). Five of the 8 permanent complications (2.6% overall) were ischemic, and 3 of 8 (1.6% overall) were hemorrhagic. Of the 178 patients who were mRS 0-2 pre-embolization, 4 (2.3%) were dependent or dead (mRS >2) at follow-up. Univariate analysis of risk factors for permanent neurologic deficits following embolization showed that basal ganglia location was weakly associated with a new postembolization neurologic deficit. CONCLUSION: Embolization of brain AVMs can be performed with a high degree of technical success and a low rate of permanent neurologic complications.
Authors:
M V Jayaraman; M L Marcellus; S Hamilton; H M Do; D Campbell; S D Chang; G K Steinberg; M P Marks
Related Documents :
14975413 - Intracerebral haemorrhage: surgical therapy vs. patient-adapted treatment concept.
20376743 - Treatment of idiopathic hemifacial spasm with radiosurgery or hypofractionated stereota...
18709783 - Treatment of pilonidal sinus with primary closure. a twenty-year experience.
Publication Detail:
Type:  Journal Article     Date:  2007-11-01
Journal Detail:
Title:  AJNR. American journal of neuroradiology     Volume:  29     ISSN:  1936-959X     ISO Abbreviation:  AJNR Am J Neuroradiol     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-14     Completed Date:  2008-04-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003708     Medline TA:  AJNR Am J Neuroradiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  242-6     Citation Subset:  IM    
Affiliation:
Department of Radiology, Stanford University Medical Center, Stanford, Calif., USA. mjayaraman@lifespan.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
California / epidemiology
Comorbidity
Embolization, Therapeutic / statistics & numerical data*
Female
Hemostatics / therapeutic use*
Humans
Incidence
Intracranial Arteriovenous Malformations / epidemiology*,  therapy*
Male
Nervous System Diseases / epidemiology*,  therapy*
Retrospective Studies
Risk Assessment / methods*
Risk Factors
Solutions
Chemical
Reg. No./Substance:
0/Hemostatics; 0/Solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting grade of cerebral glioma using vascular-space occupancy MR imaging.
Next Document:  Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter dis...